The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Learn how to drive organizational and cultural improvements by utilizing cost, quality, and outcome data in the decision making process. This webinar…
On-Demand Educational Webinars
This webinar explains how supplier diversity can be a valuable investment toward sustainability. Presenters define supplier diversity and the…
On-Demand Educational Webinars
We all question whether some health care supply chains outperform others, which competencies separate those supply chain professionals from t
Podcasts
In this session, Dennis Black and Dennis Orthman share their experiences and best practices to improve and expand the provider-supplier relationship.
e-Learning
Earn the Essentials of Inventory Control Certificate, this inventory management certification is a core health care supply chain discipline.
Webcast
In part 2 of the GPO or Local/Self Contracting webcast series, the panel considers the multiple product categories and the process of choosing the